G. Venkatakrishnan et al., Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase viathe epidermal growth factor receptor in ovarian cancer cells, J BIOL CHEM, 275(10), 2000, pp. 6868-6875
Ovarian cancer typically disseminates widely in the abdomen, a characterist
ic that limits curative therapy. The mechanisms that promote ovarian cancer
cell migration are incompletely understood. We studied model SK-OV-3 ovari
an cancer cells and observed robust expression of the gamma chemokine recep
tors CXCR-1 and CXCR-2. Interleukin-8 (IL-8) treatment caused shape changes
in the cells, with membrane ruffling and formation/retraction of thin acti
n-like projections, as detected by time-lapse microscopy. Stimulation of th
e CXCR-1/2 receptors by human interleukin 8 (IL-8) rapidly activated the p4
4/42 mitogen-activated protein (extracellular signal-regulated kinase (Erk1
/2)) kinase pathway. Treatment of SK-OV-3 cells with the inhibitors geneste
in and herbimycin A indicated that tyrosine kinases were involved in the IL
-8 activation of Erk1 and Erk2. Of note, IL-8 induced transient phosphoryla
tion of the epidermal growth factor (EGF) receptor and its association with
the adaptor molecules Shc and Grb2. This transactivation of the EGF recept
or was dependent on intracellular Ca2+ mobilization. Furthermore AG1478, a
specific inhibitor of the EGF receptor kinase, blocked Erk1 and Erk2 activa
tion. c-Src kinase was not involved in the LL-g-mediated phosphorylation of
the EGF receptor, but was critical for Shc phosphorylation and downstream
Erk1/2 kinase activation. These results suggest important "cross-talk" betw
een chemokine and growth factor pathways that may link signals of cell migr
ation and proliferation in ovarian cancer.